To investigate the role of PFKL and G6PD in tumor growth in vivo, we injected control, PFKL-overexpressing, and G6PD-overexpressing HCT116 cells, each with and without TAp73-knockdown, into immune compromised mice. Here, G6PD is linked to neoplasm.